IRIS
GRILLONE, KATIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 310
EU - Europa 296
AS - Asia 107
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 715
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 304
IT - Italia 211
SG - Singapore 84
GB - Regno Unito 21
DE - Germania 15
NL - Olanda 14
CN - Cina 10
HK - Hong Kong 7
CA - Canada 6
FI - Finlandia 6
FR - Francia 6
SE - Svezia 6
AT - Austria 4
IN - India 4
CZ - Repubblica Ceca 3
ES - Italia 3
UA - Ucraina 3
RU - Federazione Russa 2
CH - Svizzera 1
CL - Cile 1
EU - Europa 1
IR - Iran 1
PK - Pakistan 1
RO - Romania 1
Totale 715
Salva come PNG Salva come JPEG
Città #
Chandler 69
Singapore 44
Santa Clara 26
Chicago 20
London 19
Catanzaro 17
Ashburn 14
Lawrence 13
Princeton 13
Milan 12
Parma 12
Rome 10
San Nicola Manfredi 8
Hong Kong 7
Naples 7
Santo Stefano di Rogliano 7
Afragola 6
Boardman 6
Helsinki 6
Ottawa 6
Catania 5
Los Angeles 5
Melito di Porto Salvo 5
Meppel 5
Palermo 5
Brescia 4
Des Moines 4
Wilmington 4
Acquaviva delle Fonti 3
Berlin 3
Castrovillari 3
Hanover 3
Olomouc 3
Oristano 3
Paola 3
Redmond 3
San Antonio 3
Agrigento 2
Bologna 2
Campobello di Licata 2
Cosenza 2
Cropani 2
Delhi 2
Ercolano 2
Frankfurt am Main 2
Gesuiti 2
Marino 2
Munich 2
New York 2
Paris 2
Romainville 2
Serra San Bruno 2
Shanghai 2
Sorrento 2
West Lafayette 2
Ahmedabad 1
Arnhem 1
Aversa 1
Barcelona 1
Belovo 1
Bern 1
Bisignano 1
Buffalo 1
Böblingen 1
Changchun 1
Council Bluffs 1
Delta Junction 1
East Lansing 1
Eden Prairie 1
Fayetteville 1
Hyderabad 1
Kansas City 1
Lahore 1
Madrid 1
Melito di Napoli 1
Miami 1
Pachino 1
Phoenix 1
Redwood City 1
Rende 1
San Gennaro Vesuviano 1
Seattle 1
Secaucus 1
Settingiano 1
South Woodstock 1
Soverato Marina 1
Squillace 1
Taranto 1
Vallefiorita 1
Vienna 1
Washington 1
Totale 458
Salva come PNG Salva come JPEG
Nome #
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 73
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 52
Non-coding RNAs in cancer: Platforms and strategies for investigating the genomic "dark matter" 49
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 47
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. 39
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer 38
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 36
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas 35
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 33
null 31
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 30
Mir-22 modulates lenalidomide activity by counteracting myc addiction in multiple myeloma 29
Anti-tumor Activity and Epigenetic Impact of the Polyphenol Oleacein in Multiple Myeloma 27
Generation of human induced pluripotent stem cell lines (UNIMGi003-A and UNIMGi004-A) from two Italian siblings affected by Unverricht-Lundborg disease 25
Identification of different mutational profiles in cancers arising in specific colon segments by next generation sequencing 24
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes 24
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 23
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 22
Mirnas and lncrnas as novel therapeutic targets to improve cancer immunotherapy 22
Generation of iPSC lines from two patients affected by febrile seizure due to inherited missense mutation in SCN1A gene 20
From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology 14
An unbiased lncRNA dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for multiple myeloma 13
Next-generation sequencing analysis of receptor-type tyrosine kinase genes in surgically resected colon cancer: Identification of gain-of-function mutations in the RET proto-oncogene 12
UMG1/CD3ε-bispecific T-cell engager redirects T-cell cytotoxicity against diffuse large B-cell lymphoma 9
Lynch Syndrome Biopathology and Treatment: The Potential Role of microRNAs in Clinical Practice 9
Hit identification of novel small molecules interfering with MALAT1 triplex by a structure-based virtual screening 7
LNA-i-miR-221 activity in colorectal cancer: A reverse translational investigation 7
Non-Invasive Prenatal Test Analysis Opens a Pandora's Box: Identification of Very Rare Cases of SRY-Positive Healthy Females, Segregating for Three Generations Thanks to Preferential Inactivation of the XqYp Translocated Chromosome 6
A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer 6
Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer 5
Targeting non-coding RNAs: Perspectives and challenges of in-silico approaches 5
TERRA G-quadruplex stabilization behind the anti-multiple myeloma activity: Novel insights about resveratrol pleiotropic effects 5
Totale 777
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.771
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.771
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010 0 0 0 0 0 0 0 0 0 0 4 6
2020/202139 7 0 2 3 0 1 1 5 8 11 0 1
2021/202263 0 0 0 6 4 0 6 8 21 11 7 0
2022/2023240 32 20 9 10 30 17 2 13 32 32 40 3
2023/2024152 38 20 8 11 7 34 9 7 0 5 1 12
2024/2025261 41 5 7 8 37 75 27 24 32 3 2 0
Totale 777